Evidence map›Paper›PMID 31210047›Full record

ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2019

Trends in chronic disease incidence rates from the Canadian Chronic Disease Surveillance System.

Naomi C Hamm, Louise Pelletier, Joellyn Ellison, Lana Tennenhouse, Kim Reimer, J Michael Paterson, Rolf Puchtinger, Sharon Bartholomew, Karen A M Phillips, Lisa M Lix

Abstract read
In one paragraph

Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Trend control charts for multiple sclerosis case definitions.International journal of population data science · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Advanced detection strategies for cardiotropic virus infection in a cohort study of heart failure patients.Laboratory investigation; a journal of technical methods and pathology · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. At-a-glance - Twenty years of diabetes surveillance using the Canadian Chronic Disease Surveillance System.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2019
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Naomi C HammUniversity of Manitoba, Winnipeg, Manitoba, Canada.
Louise PelletierPublic Health Agency of Canada, Ottawa, Ontario, Canada.
Joellyn EllisonPublic Health Agency of Canada, Ottawa, Ontario, Canada.
Lana TennenhousePublic Health Agency of Canada, Ottawa, Ontario, Canada.
Kim ReimerBritish Columbia Ministry of Health, Victoria, British Columbia, Canada.
J Michael PatersonInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Rolf PuchtingerMinistry of Health, Government of Saskatchewan, Regina, Saskatchewan, Canada.
Sharon BartholomewPublic Health Agency of Canada, Ottawa, Ontario, Canada.
Karen A M PhillipsChief Public Health Office, Prince Edward Island Department of Health and Wellness, Charlottetown, Prince Edward Island, Canada.
Lisa M LixUniversity of Manitoba, Winnipeg, Manitoba, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Public Health Agency of Canada's Canadian Chronic Disease Surveillance System (CCDSS) produces population-based estimates of chronic disease prevalence and incidence using administrative health data. Our aim was to assess trends in incidence rates over time, trends are essential to understand changes in population risk and to inform policy development.

methodsIncident cases of diagnosed asthma, chronic obstructive pulmonary disease (COPD), diabetes, hypertension, ischemic heart disease (IHD), and stroke were obtained from the CCDSS online infobase for 1999 to 2012. Trends in national and regional incidence estimates were tested using a negative binomial regression model with year as a linear predictor. Subsequently, models with year as a restricted cubic spline were used to test for departures from linearity using the likelihood ratio test. Age and sex were covariates in all models.

resultsBased on the models with year as a linear predictor, national incidence rates were estimated to have decreased over time for all diseases, except diabetes; regional incidence rates for most diseases and regions were also estimated to have decreased. However, likelihood ratio tests revealed statistically significant departures from a linear year effect for many diseases and regions, particularly for hypertension.

conclusionChronic disease incidence estimates based on CCDSS data are decreasing over time, but not at a constant rate. Further investigations are needed to assess if this decrease is associated with changes in health status, data quality, or physician practices. As well, population characteristics that may influence changing incidence trends also require exploration.

Indexed as

CanadaChronic DiseaseFemaleHumansIncidenceMalePopulation SurveillancePrevalenceadministrative datachronic disease surveillancetrend analysis

Identifiers

PMID31210047
PMCPMC6699608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.